Amended Capital Change Notice

Capital Change Notice

Updated as at February 2025


Section 1: Issuer information
Name of issuer Promisia Healthcare Limited
NZX ticker code PHL / PHLWA
Class of financial product Ordinary Shares / Equity Warrants
ISIN (If unknown, check on NZX website) NZPRPE0001S5 / NZPHLE0002S3
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed Equity warrants in PHL (Warrants)
redeemed on exercise: 130,000

Ordinary Shares in PHL (Shares) issued
on the exercise of Warrants: 130,000

Nominal value (if any) N/A
Issue/acquisition/redemption price per security $0.50
Nature of the payment (for example, cash or other
consideration)
130,000 Shares were issued for cash on
exercise of a corresponding number of
Warrants.
Amount paid up (if not in full) Fully paid
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the
number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1

0.246% of Shares issued

0.459% of Warrants converted
For an issue of Convertible Financial Products or
Options, the principal terms of Conversion (for
example the Conversion price and Conversion date
and the ranking of the Financial Product in relation
to other Classes of Financial Product) or the Option
(for example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and
specific authority for issue/acquisition/redemption/
(the reason for change must be identified here)
Shares were issued upon the exercise of
Warrants in accordance with the terms of
issue of the Warrants.
Total number of Financial Products of the Class
after the issue/acquisition/redemption/Conversion
(excluding Treasury Stock) and the total number of
Financial Products of the Class held as Treasury
Stock after the issue/acquisition/redemption.
Shares:
52,949,550

Warrants: 28,205,000
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
N/A

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Specific authority for the issue, acquisition, or
redemption, including a reference to the rule
pursuant to which the issue, acquisition, or
redemption is made
NZX Listing Rule 4.9.1(b).
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
Warrants converted into Shares in
accordance with the Warrant Terms of
Issue.
Each Warrant can be exercised at any time
before the expiry date, being 5pm 24 March
2027, at an exercise price of $0.50 per
Warrant. Each Warrant converts to one
Share upon exercise. The Shares issued
upon conversion of the Warrants are of the
same class and terms as all other Shares.
Date of issue/acquisition/redemption
2
7/08/2026
Section 4: Authority for this announcement and contact person
Name of person

authorised to make this
announcement
Francisco Rodriguez Ferrere
Contact person for this announcement Francisco Rodriguez Ferrere
Contact phone number 021 245 1801
Contact email address Francisco.rf@promisia.co.nz
Date of release through MAP

18/08/2026




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).